Literature DB >> 2567210

Induction of nonspecific killer cells by delayed-type hypersensitivity against soluble protein antigens in murine peritoneal cavities.

T Takao1, Y Morikawa, K Kuribayashi, K Saito.   

Abstract

We induced nonspecific killer cells in the local site of delayed-type hypersensitivity against keyhole limpet hemocyanin or ovalbumin. Delayed-type hypersensitivity was induced in the peritoneal cavities of mice, and peritoneal exudate cells (PEC) were collected. These PEC were found to have killer activity toward SP2 and YAC-1 cells (target cells susceptible to natural killer cells) by 4-h 51Cr-release assays. The induction of killer activity in PEC was observed in parallel with the eliciting of delayed-type hypersensitivity in the peritoneal cavity, in which the killer activity was maximum 24-48 h after the antigen challenge, but was not induced in nu/nu mice and was induced in an antigen-specific way. These killer cells did not adhere to nylon wool and had Thy1 and asialo-GM1 antigens on their surfaces. Their precursor cells were also asialo-GM1-positive. These findings indicate that the killer cells probably belong to the NK cell lineage. Results of tumor challenge experiments showed that these killer cells had an antitumor effect in vivo as well as in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567210     DOI: 10.1007/BF00199999

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

1.  [The characteristics of the activated killer cells (AK) induced in vitro with recombinant IL-2 (rIL-2)].

Authors:  T Iwahashi; K Kuribayashi; T Takao; Y Takano; K Saito
Journal:  Arerugi       Date:  1986-10

2.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

3.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.

Authors:  R Suzuki; K Handa; K Itoh; K Kumagai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

6.  Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.

Authors:  P D Greenberg
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

7.  Effect of interleukin 2 on cytotoxic effectors: I. Short-term culture of the cytotoxic effectors and the in vivo anti-tumor activity of the cultured effectors isolated from tumor site.

Authors:  C C Ting; S S Yang
Journal:  Int J Cancer       Date:  1982-11-15       Impact factor: 7.396

8.  The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

Authors:  H Fujiwara; M Fukuzawa; T Yoshioka; H Nakajima; T Hamaoka
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

9.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus.

Authors:  H Mitsuya; L A Matis; M Megson; P A Bunn; C Murray; D L Mann; R C Gallo; S Broder
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.